110545-79-4

Basic information

• Product Name: 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyridin-5(7H)-one
• CAS NO: 110545-79-4
• Molecular Formula: C₁₈H₁₅ClN₂O
• Molecular Weight: 310.7775
• Mol File: 110545-79-4.mol

Chemical Properties

• Boiling Point: 484.6°C at 760 mmHg
• Flash Point: 246.9°C
• Density: 1.36g/cm³
• Vapor Pressure: 1.52E-09mmHg at 25°C
• Refractive Index: 1.68
• CAS DataBase Reference: 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyridin-5(7H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyridin-5(7H)-one(110545-79-4)
• EPA Substance Registry System: 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyridin-5(7H)-one(110545-79-4)

Safety Data

• Hazardous Substances Data: 110545-79-4(Hazardous Substances Data)

Usage

Molecular structure

The compound has a complex molecular structure that includes a benzene ring and a naphthyridine ring.

3-chlorophenyl group

The presence of a 3-chlorophenyl group in its structure denotes a chlorine atom attached to a phenyl group, which may confer specific chemical properties to the compound.

Tetrahydrobenzo[b][1,8]naphthyridin-5(7H)-one backbone

The compound has a tetrahydrobenzo[b][1,8]naphthyridin-5(7H)-one backbone, which is likely to have pharmacological relevance.

Potential applications

The compound may serve as a scaffold for drug development or as a biological probe in research.

Contribution to medicinal chemistry

Further study and characterization of this compound could contribute to the advancement of medicinal chemistry and pharmaceutical innovation.

Chemical properties

The compound may exhibit specific chemical properties due to the presence of the 3-chlorophenyl group.

Biological activity

The compound may have potential biological activity due to its complex molecular structure and pharmacological relevance.

Synthesis

The compound may be synthesized through various chemical reactions and techniques.

Stability

The compound may have specific stability properties depending on its molecular structure and functional groups.

Solubility

The compound's solubility properties may be influenced by its molecular structure and functional groups.

Upstream product

• 1125-99-1 1-(1-Cyclohexen-1-yl)pyrrolidine 
• 110546-46-8 2-<(3-chlorophenyl)amino>-3-pyridinecarbonyl chloride 
• 108-42-9 3-chloro-aniline 
• 110545-74-9 (2-chloro-3-pyridinyl)<2-(4-morpholinyl)-1-cyclohexen-1-yl>methanone 
• 153615-34-0 2-<(2-chloro-3-pyridinyl)carbonyl>-1-cyclohexen-1-yl-2-chloro-3-pyridinecarboxylate 
• 153615-30-6 (2-chloro-3-pyridinyl)<2-<(3-chlorophenyl)amino>-1-cyclohexen-1-yl>methanone 
• 670-80-4 4-cyclohexen-1-ylmorpholine 
• 49609-84-9 2-Chloronicotinoyl chloride 

Downstream Products

• 138963-11-8 12-(3-Chlorophenyl)-7,8,9,10-tetrahydro-6-hydroxypyrido<2,3-b>azecine-5,11(6H,12H)-dione 
• 138963-10-7 12-(3-Chlorophenyl)-7,8,9,10-tetrahydropyrido<2,3-b>azecine-5,6,11(12H)-trione 

Relevant articles and documents

Intramolecular transaminations of enaminones: A synthesis of fused, polycyclic, N-aryl pyridones

2-Arylamino-3-pyridinecarbonyl chlorides acylated the β-carbon atoms of enamines, and the resulting enaminones cyclized to give a series of fused polycyclic N-aryl pyridones. The series included 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyr

The chemical reactivity of a known anti-psoriasis drug. Part 1: Further insights into the products resulting from oxidative cleavage

The oxidative cleavage of the known anti-psoriasis drug 1 to give 2 has been reported previously. Due to the importance of accessing medium-sized ring containing systems via oxidative cleavage, this reaction has been revisited revealing additional informa

Synthesis and characterisation of medium-sized ring systems by oxidative cleavage. Part 2: Insights from the study of ring expanded analogues

Variable temperature NMR analysis and computational methods have been used to develop a detailed understanding of the 1H NMR spectra of a family of medium-sized ring containing compounds. The family consists of analogues containing 10-, 11- and

Intermolecular Transaminations of Enaminones: A Synthesis of Fused, Polycyclic, N-Aryl Pyridones

Aryl amines reacted with enaminones like (2-chloro-3-pyridinyl)methanone, and the transaminated products cyclized to aryl-substituted pyridones like 6,7,8,9-tetrahydro-9-phenyl-5H-cyclopentanaphthyridin-5-one

Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives

Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treating allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune respo